 CAMBRIDGE, Mass., May 10, 2022 GLOBE NEWSWIRE -- Wave Life Sciences Ltd. Nasdaq: WVE, a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in two upcoming investors conferences in May. 